Cetirizine Hydrochloride

ApprovedSmall molecule

GSK

Cetirizine Hydrochloride is one of 89 small molecule programs targeting Neuropathic Pain. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Neuropathic PainActive, not recruiting

UrticariaActive, not recruiting

Neuropathic PainApproved

Active, not recruiting

UrticariaPhase 3

Active, not recruiting

Competition

Competitive Landscape

212 competitors in Neuropathic Pain

#DrugCompanyPhaseTrials

Elavil

AstraZeneca

Phase 3

4 2

Namenda

AbbVie

Phase 3

3 3

Xylocaine

MMEDRx USA, Inc.

Phase 3

9 4

Briviact

UCB

Phase 3

1 5

Sativex

Jazz Pharmaceuticals

Phase 3

6 6

Ultram

WWim Janssens

Phase 3

2 7

Ketalar

Boehringer Ingelheim

Phase 3

2 8

Ultiva

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Phase 3

2 9

Aspercreme Warming

AAveritas Pharma, Inc.

Phase 3

1 10

Marcaine

IInnocoll

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Fed2 trials

Bioequivalence Study of Cetirizine Hydrochloride 10mg Tablets Under Fed Conditions

Completed·RRanbaxy Laboratories Limited·N/A·NCT00776022·32 enrolled

Cetirizine Hydrochloride Tablets, 10 mg Bioequivalence Study of Dr.Reddy's Under Fed Condition

Completed·—·Phase 1·NCT01064115·30 enrolled

Pelvic Pain1 trial

Mast Cells in Male Pelvic Pain and and Lower Urinary Tract Dysfunction

Completed·NNorthwestern University·Phase 1·NCT03167216·20 enrolled

MRI Scan1 trial

A Study To Investigate If MRI Scanning Is Effective At Seeing What Hayfever Drugs Do In Nasal Passage.

Completed· GSK logo

GSK··NCT00517946·21 enrolled

Urticaria1 trial

Phase III Clinical Study of Cetirizine Hydrochloride Injection in Treatment of Acute Urticaria

Recruiting·SShandong New Time Pharmaceutical Co., LTD·Phase 3·NCT06819774·284 enrolled

Fasting Conditions1 trial

Bioequivalence Study of Cetirizine Hydrochloride 10mg Tablets Under Fasting Conditions

Completed·RRanbaxy Laboratories Limited·N/A·NCT00776139·32 enrolled

2 more indications

Neuropathic Pain1 trial

Transporters for Organic Cations and Glycemic Control in Patients With Neuropathic Pain.

Completed·NNatalia Valadares de Moraes·Phase 4·NCT03047278·29 enrolled

Unspecified1 trial

Cetirizine Hydrochloride Tablets, 10 mg Bioequivalence Study of Dr.Reddy's Under Fasting Condition

Completed·—·Phase 1·NCT01064102·30 enrolled

Sources

References

[1]
ClinicalTrials.gov — 8 trial records for Cetirizine Hydrochloride. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Cetirizine Hydrochloride compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Cetirizine Hydrochloride. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — GSK company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: GSK

Cetirizine Hydrochloride

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Fed2 trials

Pelvic Pain1 trial

MRI Scan1 trial

Urticaria1 trial

Fasting Conditions1 trial

Neuropathic Pain1 trial

Unspecified1 trial

References

Drug Info

Quick Facts

Related News